[go: up one dir, main page]

Reuveni et al., 2020 - Google Patents

MuSK EAMG: immunological characterization and suppression by induction of oral tolerance

Reuveni et al., 2020

View HTML
Document ID
7746576065588997090
Author
Reuveni D
Aricha R
Souroujon M
Fuchs S
Publication year
Publication venue
Frontiers in Immunology

External Links

Snippet

Myasthenia gravis (MG) with antibodies to the muscle-specific receptor tyrosine kinase (MuSK) is a distinct sub-group of MG, affecting 5–8% of all MG patients. MuSK, a receptor tyrosine kinase, is expressed at the neuromuscular junctions (NMJs) from the earliest stages …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Liu et al. Cooperation of invariant NKT cells and CD4+ CD25+ T regulatory cells in the prevention of autoimmune myasthenia
Samy et al. Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+ CD25+ regulatory T cells in the regional lymph node
Pöllinger et al. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells
Wolf et al. Experimental autoimmune encephalomyelitis induction in genetically B cell–deficient mice
Trembleau et al. Deviation of pancreas‐infiltrating cells to Th2 by interleukin‐12 antagonist administration inhibits autoimmune diabetes
Krishnamoorthy et al. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation
Kühl et al. Human peripheral γδ T cells possess regulatory potential
Bensinger et al. Major histocompatibility complex class II–positive cortical epithelium mediates the selection of CD4+ 25+ immunoregulatory T cells
Avichezer et al. An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms
Miellot et al. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL‐10‐dependent pathway
US20070286849A1 (en) Treatment of autoimmune disorders
Berer et al. B cells in spontaneous autoimmune diseases of the central nervous system
Svensson et al. γδ T cells contribute to the systemic immunoglobulin E response and local B‐cell reactivity in allergic eosinophilic airway inflammation
Hoehlig et al. Activation of CD 4+ F oxp3+ regulatory T cells proceeds normally in the absence of B cells during EAE
Li et al. Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis
BACH Autoimmune diseases as the loss of active “self‐control”
Costanza et al. Prolactin is not required for the development of severe chronic experimental autoimmune encephalomyelitis
Taylor et al. Enhanced tolerance to autoimmune uveitis in CD200-deficient mice correlates with a pronounced Th2 switch in response to antigen challenge
US8629108B2 (en) Rheumatoid arthritis T cell vaccine
Reuveni et al. MuSK EAMG: immunological characterization and suppression by induction of oral tolerance
Liao et al. Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis
Pelegrí et al. Depletion of γ/δ T cells does not prevent or ameliorate, but rather aggravates, rat adjuvant arthritis
Takayama et al. Regulatory role of Peyer’s patches for the inhibition of OVA-induced allergic diarrhea
Fu et al. TIGIT-Fc as a potential therapeutic agent for fetomaternal tolerance
Yamana et al. Mucosal-associated invariant T cells have therapeutic potential against ocular autoimmunity